-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENTALIS PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN DENALI PART 2 CLINICAL TRIAL OF AZENOSERTIB IN PATIENTS WITH CYCLIN E1+ PROC

Reuters·04/28/2025 12:00:03

Please log in to view news